- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
The drugmaker is poised to overcome current lawsuits and patent-expiration woes.
Occasional price hikes combined with a healthy comp sales growth should ensure the restaurant chain is able to maintain its margins in the long run.
The exchange has wasted no time expanding its European operations.
If people pay more for vehicles, they may pay more for satellite radio.
Low-cost smartphones have entered the market and the carriers subsidize even expensive handsets.
The company is outpacing Walgreen and Wal-Mart with its MinuteClinics.
A favorable ruling would have created an opportunity for Barrick to strengthen its position in South America.
The partnership is an effective tool for Anadarko to reduce the risk associated with its Lucius project in the Gulf of Mexico.
Payments via phones are gaining increasing popularity and the credit-card giant wants to cash in.
The integration could mean a major boost in Yelp's ad revenue.